Growth factor expression of human arterial smooth muscle cells and endothelial cells in a transfilter coculture system

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 11, 1997, Pages 2967-2978

  Axel, Dorothea I ^a   Riessen, Reimer ^b   Athanasiadis, Anastasios ^b   Runge, Heike ^b   Köveker, Gerhard ^b   Karsch, Karl R ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

Cell cell interactions; Cocultures; Growth factor expression; Human arterial endothelial cells; Human arterial smooth muscle cells; Platelet derived growth factor; Transforming growth factor 1; Tumor necrosis factor

Indexed keywords

GROWTH FACTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTERY WALL; ARTICLE; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TIME;

EID: 0031281373     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0541     Document Type: Article

References (44)

1. AXEL DI, BREHM BR, WOLBURG-BUCHHOLZ K, BETZ EL, KÖVEKER G, KARSCH KR, 1996a. Induction of cell-rich and lipid-rich plaques in a transfilter coculture system with human vascular cells. J Vasc Res 33: 327-339.
2. AXEL DI, RIESSEN R, ATHANASIADIS A, RUNGE H, HERZOG U, KÖVEKER G, KARSCH KR, 1996b. Differences in platelet-derived growth factor A- and B-chain mRNA-expression by human arterial smooth muscle cells and endothelial cells depending on growth stage and cell density. (Abstract) Eur Heart J 17: 195.
3. AXEL DI, KUNERT W, GÖGGELMANN C, OBERHOEE M, HERDEG C, KÜTTNER A, WILD DH, BREHM BR, RIESSEN R, KÖVEKER G, KARSCH KR, 1997. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96: 636-645.
4. BARRETT TB, BENDITT EP, 1988. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA 85: 2810-2814.
5. CASSCELLS W, 1991. Smooth muscle cell growth factors. Prog Growth Fact Res 3: 177-206.
6. CERCEK B, SHARIFI B, BARATH P, BAILEY L, FORRESTER JS, 1991. Growth factors in pathogenesis of coronary arterial restenosis. Am J Cardiol 68: 24C-33C.
7. COLLINS T, GINSBURG D, Boss JM, ORKIN SH, POBER JS, 1985. Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748-750.
8. COLLINS T, BONTHRON DT, ORKIN SH, 1987. Alternative RNA splicing affects function of encoded platelet-derived growth factor A chain. Nature 328: 621-624.
9. CROWLEY ST, RAY CJ, NAWAZ D, MAJACK RA, HORWITZ LD, 1995. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 269: H1641-H1647.
10. D'AMORE PA, SMITH SR, 1993. Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8: 61-75.
11. DENIZOT F, LANG R, 1986. Rapid colorimetric assay for cell growth and survival. J Immunol Meth 89: 271-277.
12. DERNYCK R, JARRET JA, CHEN EY, EATON DH, BELL J, ASSOIAN RK, ROBERTS AB, SPORN MB, GOEDDEL DV, 1985. Human transforming growth factor-β cDNA sequence and expression in tumor cell lines. Nature 316: 701-705.
13. DOSQUET C, WEILL D, WAUTIER JL, 1996. Cytokines and thrombosis. J Cardiovasc Pharmacol 25: S13-S19.
14. 32P-based hybridizations. Anal Biochem 210: 235-244.
15. FALLIER-BECKER P, BETZ E, WOLBURG-BUCHHOLZ K, FOTEV Z, 1991. Fibromuscular proliferates induced in vitro using a transfilter culture system. Res Exp Med 191: 11-25.
16. FLEET JC, CLINTON SK, SALOMON RN, LOPPNOW H, LIBBY P, 1992. Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. J Nutr 122: 294-305.
17. Fox PL, DICORLETO PE, 1984. Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells. J Cell Physiol 121: 298-308.
18. FUSTER V, BADIMON JJ, BADIMON L, 1992. Clinical-pathology correlations of coronary disease progression and regression. Circulation 86: III-1-III-11.
19. GOLDEN MA, AU YP, KIRKMAN TR, WILCOX JN, RAINES EW, ROSS R, CLOWES AW, 1991. Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons: association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. J Clin Invest 87: 406-414.
20. GRATZNER HG, 1982. Monoclonal antibody to 5-bromo- and 5-jododesoxyuridine: a new reagent for detection of DNA replication. Science 218: 474-475.
21. HSIEH HJ, LI NQ, FRANGOS JA, 1991. Shear stress increases endothelial platelet-derived growth factor mRNA levels. Am J Physiol 260: H642-H646.
22. KATO S, SHANLEY JR, Fox JC, 1996. Serum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. Am J Pathol 149: 687-697.
23. KAZLAUSKAS A, BOWEN-POPE D, SEIFERT R, HART E, COOPER JA, 1988. Different effects of homo- and heterodimers of platelet derived growth factor A and B chain on human and mouse fibroblasts. EMBO J 7: 3727-3735.
24. LIBBY P, SCHWARTZ D, BROGI E, TANAKA H, CLINTON SK, 1992. A cascade model for restenosis. Circulation 86: III-47-III-52.
25. LINDNER V, GIACHELLI CM, SCHWARTZ SM, REIDY MA, 1995. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor B chain mRNA. Circ Res 76: 951-957.
26. MAJACK RA, 1987. β-type transforming growth factor species organizational behaviour in vascular smooth muscle cell cultures. J Cell Biol 105: 465-471.
27. MAJACK RA, MAJESKY MW, GOODMAN LV, 1990. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol 111: 239-247.
28. MAJESKY MW, REIDY MA, BOWEN-POPE DF, HART CE, WILCOX JN, SCHWARTZ SM, 1990. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 111: 2149-2158.
29. MIANO JM, VLASIC N, STEMERMAN MB, 1993. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury. Arterioscler Thromb 13: 211-219.
30. MURRY CE, BARTOSEK T, GIACHELLI CM, ALPERS CE, SCHWARTZ SM, 1996. Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aorta. Circulation 93: 1095-1106.
31. NILSSON J, VOLK-JOVINGE S, SVENSSON J, LANDOU C, DE FAIRE U, HAMSTEN A, 1992. Association between high levels of growth factors in plasma and progression of coronary atherosclerosis. J Int Med 232: 397-404.
32. REIDY A, FINGERLE J, LINDNER V, 1992. Factors controlling the development of arterial lesions after injury. Circulation 86: III-43-III-46.
33. REKHTER MD, GORDON D, 1994. Does platelet-derived growth factor-A chain stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques? Circ Res 75: 410-417.
34. Ross R, 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-808.
35. ROTH DR, AXEL DI, BETZ EL, 1993. In vitro model of the inner parts of a vessel wall with cultured human vascular cells. Coron Art Dis 4: 283-291.
36. RUSSELL WE, COFFEY RJ JR, OUELLETTE AJ, MOSES HL, 1988. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85: 5126-5130.
37. SCHWARTZ SM, DEBLOIS D, O'BRIEN RM, 1995. The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465.
38. SCOTT-BURDEN T, SCHINI VB, ELIZONDO E, JUNQUERO DC, VANHOUTTE PM, 1992. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circ Res 71: 1088-1100.
39. STAVRI GT, ZACHARY IC, BASKERVILLE PA, MARTIN JF, ERUSALIMSKY JD, 1995. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Circulation 92: 11-14.
40. STOUFFER GA, OWENS GK, 1994. TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanism. J Clin Invest 93: 2048-2055.
41. WALLENSTEIN S, ZUCKER CL, FLEISS JL, 1980. Some statistical methods useful in circulation research. Circ Res 47: 1-9.
42. WARNER SJC, LIBBY P, 1989. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol 142: 100-109.
43. WILCOX JN, 1993. Molecular biology: insight into the causes and prevention of restenosis after arterial intervention. Am J Cardiol 72: 88E-95E.
44. WILCOX JN, SMITH KM, WILLIAMS LT, SCHWARTZ SM, GORDON D, 1988. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 82: 1134-1143.